Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03657043
Recruitment Status : Recruiting
First Posted : September 4, 2018
Last Update Posted : February 2, 2021
Sponsor:
Collaborator:
Genmab
Information provided by (Responsible Party):
Seagen Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 31, 2022
Estimated Study Completion Date : August 31, 2022